Polaris Venture Management Co. V as of June 30, 2020
Portfolio Holdings for Polaris Venture Management Co. V
Polaris Venture Management Co. V holds 10 positions in its portfolio as reported in the June 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Phreesia Common Stock | 48.7 | $63M | 2.2M | 28.28 | |
| Fate Therapeutics Common Stock (FATE) | 30.4 | $39M | 1.1M | 34.31 | |
| Lyra Therapeutics Common Stock (LYRA) | 9.7 | $13M | 1.1M | 11.34 | |
| Selecta Biosciences Common Stock (RNAC) | 6.1 | $7.9M | 2.8M | 2.84 | |
| x4 Pharmaceuticals Common Stock (XFOR) | 2.3 | $2.9M | 312k | 9.32 | |
| Neuronetics Common Stock (STIM) | 1.1 | $1.4M | 733k | 1.93 | |
| Pulmatrix Common Stock | 0.5 | $618k | 359k | 1.72 | |
| Atyr Pharma Common Stock | 0.5 | $580k | 131k | 4.44 | |
| Genocea Biosciences Common Stock (GNCAQ) | 0.4 | $566k | 246k | 2.30 | |
| Dare Bioscience Common Stock (DARE) | 0.3 | $323k | 326k | 0.99 |
